Drusolv Therapeutics
Biotechnology Research
Philadelphia, Pennsylvania, United States
6 employees
- Employees
- 6
Drusolv Therapeutics Overview
- Headquarters
- Philadelphia, Pennsylvania, United States
- Website
- www.drusolv.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2017
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Drusolv Therapeutics
Drusolv Therapeutics is a clinical-stage drug company focused on development of a novel, high-dose statin for early intervention in a blinding eye disease called age-related macular degeneration (AMD).
Compare Similar Companies to Drusolv Therapeutics
Baudax Bio
Pharmaceutical Manufacturing
AdaptDx Pro
Medical Equipment Manufacturing
EpiVario, Inc.
Biotechnology Research
Intrance Medical Systems
Pharmaceutical Manufacturing
Qrono Inc.
Pharmaceutical Manufacturing
11.2 Capital
Venture Capital And Private Equity Principals
GGS Associates
Business Consulting And Services
Ambrose Healthcare
Hospitals And Health Care
Apeliotus Technologies
Medical Device
Fonseca Biosciences
Pharmaceutical Manufacturing